欧美成人动漫日韩国庆_亚洲天堂自拍偷拍_人妻少妇边接电话边娇喘_新婚少妇交换杨雨婷_高清不卡一区二区在线观看_亚洲国产中文另类久久久精品网站_十八禁裸体自慰免费观看_日本亚洲中文有码_日本人zzzwww色视频直播_国产福利姬在线观看

d3-pcbanner-33.jpg d3-phbanner.jpg
Clinical Trials
A Randomized, Single blind, Placebo Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of Subcutaneously Administered RBD4059 in Healthy Subjects

“A Randomized, Single-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of Subcutaneously Administered RBD5044 in Healthy Subjects”, this study is ongoing in Australia. the study is currently in the single-dose incremental enrolment phase.

Learn More
A Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of Subcutaneously Administered RBD5044 in Healthy Subjects

“A Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of Subcutaneously Administered RBD5044 in Healthy Subjects”, this study is ongoing in Australia. The study has completed enrolment in the single dose-escalation phase, and is currently in the multiple dose-escalation enrolment phase.

Learn More
A single and repeated dose escalation study to evaluate the safety, tolerability, pharmacokinetics and preliminary pharmacodynamics of RBD7022 in subjects with normal or elevated LDL cholesterol

“A randomized, single-blind, placebo-controlled, single-center, single-dose-escalation, and multi-dose-escalation phase I trial evaluated the safety, tolerability, pharmacokinetic, and preliminary pharmacodynamic characteristics of subcutaneous RBD7022 in subjects with normal or elevated LDL cholesterol” is ongoing.

Learn More
A single and repeated dose escalation study to evaluate the safety, pharmacokinetics and preliminary pharmacodynamics of RBD1016 in subjects with chronic hepatitis B virus (HBV) infection

" A Single and Repeated Dose Escalation, Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics and Preliminary Pharmacodynamics of?RBD1016?in Subjects With Chronic Hepatitis B Virus (HBV) Infection“, has been Completed in Hong Kong, China.

Learn More
A clinical trial to evaluate the safety and pharmacokinetics of RBD1016 in healthy subjects

“A randomized, double-blind, placebo-controlled, single-dose escalation phase Ia clinical Study to evaluate the safety and pharmacokinetics of RBD1016 in healthy subjects” has been completed in Australia.

Learn More